Anti-RBD, anti-S1, and anti-trimeric spike protein IgG titers as well as the neutralizing serum activity against WT and BA.1 were available for 48 HD patients vaccinated with four doses of either mRNA vaccine (Figure 3, Supplemental Figure S1). This evidence concerns the gene CFB and Huntington disease.